These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 4211148)

  • 1. Nicotinic acid plasma concentrations after ingestion of 1,3,4,6-tetranicotinoyl-fructo-furanose (tetranicotinoylfructose, nicofuranose).
    Salmi HA; Frey H
    Curr Ther Res Clin Exp; 1974 Jun; 16(6):669-74. PubMed ID: 4211148
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of the absorption of xanthinol nicotinate from slow-release and plain tablets in man.
    Sharma PL; Garg SK; Sikka SC
    Int J Clin Pharmacol; 1973 Jul; 7(4):299-302. PubMed ID: 4146912
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution to the therapy of blood circulation disorders with tetranicotinoyl-fructofuranose (Nicofuranose)].
    Pankiewicz F
    Ther Umsch; 1965 Oct; 22(10):494-7. PubMed ID: 5882062
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
    Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of nicotinic acid and its two metabolites in human plasma using solid-phase extraction in combination with high performance liquid chromatography.
    Miyauchi Y; Sano N; Nakamura T
    Int J Vitam Nutr Res; 1993; 63(2):145-9. PubMed ID: 8407165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetranicotinoylfructose in disorders of digital blood flow.
    Holti G; Newell DJ; Poole HG
    Practitioner; 1971 Nov; 207(241):654-8. PubMed ID: 4944129
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison between the absorption of nicotinic acid and pentaerythritol tetranicotinate (Perycit) from ordinary and enterocoated tablets.
    Svedmyr N; Harthon L
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):66-74. PubMed ID: 5467756
    [No Abstract]   [Full Text] [Related]  

  • 8. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.
    Gourlay SG; Benowitz NL
    Clin Pharmacol Ther; 1997 Oct; 62(4):453-63. PubMed ID: 9357397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of tetranicotinoylfructose in peripheral vascular disease.
    Andrews G; Judge TG; Walkey F
    Practitioner; 1973 Jul; 211(261):83-5. PubMed ID: 4580277
    [No Abstract]   [Full Text] [Related]  

  • 10. Nicotine substitutes and pregnancy.
    Prescrire Int; 2001 Aug; 10(54):116-7. PubMed ID: 11718181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of nicotine addiction. Drug therapy for smoking cessation].
    Pedersen ST; Christensen HR; Døssing M
    Ugeskr Laeger; 2002 Mar; 164(11):1480-4. PubMed ID: 11924470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers.
    Sun HQ; Guo S; Chen DF; Jiang ZN; Liu Y; Di XL; Yang FD; Zhang XY; Kosten TR; Lu L
    Am J Drug Alcohol Abuse; 2009; 35(3):183-8. PubMed ID: 19462302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
    Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ
    Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.
    Bhagavan HN; Chopra RK
    Mitochondrion; 2007 Jun; 7 Suppl():S78-88. PubMed ID: 17482886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption and excretion of radioactive pentaerythritoltetranicotinate, mesoinositolhexanicotinate and nicotinic acid after oral administration to cat.
    Brattsand R; Harthon L
    Arzneimittelforschung; 1971 Sep; 21(9):1335-8. PubMed ID: 5171788
    [No Abstract]   [Full Text] [Related]  

  • 16. Nicotine replacement lozenges: abuse-related hyperkeratosis of the lateral border of the tongue. A case report.
    Naudi KB; Felix DH
    Br Dent J; 2007 Sep; 203(6):305-6. PubMed ID: 17891080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine-replacement products in smoking cessation: a review.
    Alsagoff F; Lee HP
    Singapore Med J; 1993 Dec; 34(6):505-10. PubMed ID: 8153711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma concentrations of proxyphylline (Neofyllin) following repeated administration. Comparative investigations with 2 dispensing forms for oral use].
    Folkenborg O
    Ugeskr Laeger; 1972 Feb; 134(6):266-9. PubMed ID: 5010244
    [No Abstract]   [Full Text] [Related]  

  • 19. [Smoking cessation with the nicotine patch].
    Batra A; Buchkremer G
    Z Arztl Fortbild (Jena); 1995 Oct; 89(5):505-9. PubMed ID: 8578778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine chewing gum and nicotine patch.
    Fagerström KO; Tönnesen P
    Wien Med Wochenschr; 1995; 145(4):77-82. PubMed ID: 7778323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.